These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3474759)

  • 21. [Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
    Naumann P; Dopp C
    Internist (Berl); 1989 Jan; 30(1):20-31. PubMed ID: 2646237
    [No Abstract]   [Full Text] [Related]  

  • 22. [Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
    Fourrier F; Chopin C; Lestavel P; Savage C
    Presse Med; 1986 Jun; 15(26):1240. PubMed ID: 2944094
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of quinolones in staphylococcal infection.
    Shah PM
    J Chemother; 1989 Aug; 1(4):253-6. PubMed ID: 2809692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
    Groeneveld AJ; Brouwers JR
    Pharm Weekbl Sci; 1986 Feb; 8(1):79-84. PubMed ID: 2938073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gyrase inhibitors: unwanted central nervous system effects].
    Rietbrock N; Staib AH
    Dtsch Med Wochenschr; 1987 Jan; 112(5):201. PubMed ID: 3467948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biotransformation of selected gyrase inhibitors].
    Borner K; Lode H
    Infection; 1986; 14 Suppl 1():S54-9. PubMed ID: 3007367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility to quinolones of Salmonella isolated from men and animals].
    Avril JL; Couete I; Travert MF; Autuly F; Plessis P
    Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ofloxacin: therapeutic activity in experimental infections.
    Guerra L; Erani E; Xerri L
    Chemioterapia; 1986 Dec; 5(6):375-8. PubMed ID: 3467874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
    Hooper DC; Wolfson JS
    Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S72-5. PubMed ID: 3481439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
    Shcherbaniuk AI; Lozovoĭ NV; Kasatkina IV; Pasiukov VV
    Antibiot Khimioter; 1994 Jun; 39(6):13-4. PubMed ID: 7847999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ofloxacin in the treatment of gynecologic and obstetrical infections].
    Grcić R; Ivanović L; Stavrić V; Kadija D; Miković Z
    Med Pregl; 1987; 40(3-4):129-32. PubMed ID: 3478554
    [No Abstract]   [Full Text] [Related]  

  • 37. [The future of quinolones].
    Gomis M; Ledesma F
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):463-5. PubMed ID: 9011201
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections].
    Guibert J; Acar JF
    Pathol Biol (Paris); 1986 May; 34(5):494-7. PubMed ID: 3534729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ofloxacin versus doxycycline in gynecological infections.
    Schneider A; Weissenbacher ER; Gutschow K; Wachter I
    Acta Eur Fertil; 1987; 18(2):121-2. PubMed ID: 3477052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.
    Pattyn SR
    Antimicrob Agents Chemother; 1987 Apr; 31(4):671-2. PubMed ID: 3475035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.